Loading…
Lobbying Spend
—
Filings
54
Firms Hired
1
Active Period
2014–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicare Patient Access to Cancer Treatment Act of 2015
2016 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
The Medicare Patient Access to Cancer Treatment Act (H.R. 2895) The Preserve Community Care Cancer Act (H.R. 696 / S. 506)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
The Medicare Patient Access to Cancer Treatment Act (H.R. 2895) The Preserve Community Care Cancer Act (H.R. 696 / S. 506)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 696
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
The Medicare Patient Access to Cancer Treatment Act (H.R. 2895) The Preserve Community Care Cancer Act (H.R. 696 / S. 506)
Client expense: — · Firm income: $40,500
Matched citations: S. 506
Cancer Patient Protection Act of 2015
2016 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Oppose proposed Medicare Part B drug payment demonstration (no specific bill)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
Medicare Patient Access to Cancer Treatment Act of 2015
2016 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Oppose proposed Medicare Part B drug payment demonstration (no specific bill)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Oppose proposed Medicare Part B drug payment demonstration (no specific bill)
Client expense: — · Firm income: $40,500
Matched citations: HR 696
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Oppose proposed Medicare Part B drug payment demonstration (no specific bill)
Client expense: — · Firm income: $40,500
Matched citations: S 506
Cancer Patient Protection Act of 2015
2016 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
Medicare Patient Access to Cancer Treatment Act of 2015
2016 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: HR 696
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, (HR 696 / S 506) - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: S 506
Cancer Patient Protection Act of 2015
2015 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
Medicare Patient Access to Cancer Treatment Act of 2015
2015 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2015 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
- Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: HR 696
Cancer Patient Protection Act of 2015
2015 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
Medicare Patient Access to Cancer Treatment Act of 2015
2015 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2015 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services
Client expense: — · Firm income: $40,500
Matched citations: HR 696
Bipartisan Budget Act of 2015
2015 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Opposition to Sec. 212, MODIFICATION OF THE MEDICARE SEQUESTER FOR FISCAL YEAR 2024, as included in legislation (H.R. 1314)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1314
Cancer Patient Protection Act of 2015
2015 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Opposition to Sec. 212, MODIFICATION OF THE MEDICARE SEQUESTER FOR FISCAL YEAR 2024, as included in legislation (H.R. 1314)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
Medicare Patient Access to Cancer Treatment Act of 2015
2015 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Opposition to Sec. 212, MODIFICATION OF THE MEDICARE SEQUESTER FOR FISCAL YEAR 2024, as included in legislation (H.R. 1314)
Client expense: — · Firm income: $40,500
Matched citations: H.R. 2895
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2015 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare, - Medicare Patient Access to Cancer Treatment Act (H.R. 2895) - Prompt pay discount legislation, HR 696 - H.R. 1416 The Cancer Patient Protection Act of 2015 - site neutrality for ambulatory oncology services - Opposition to Sec. 212, MODIFICATION OF THE MEDICARE SEQUESTER FOR FISCAL YEAR 2024, as included in legislation (H.R. 1314)
Client expense: — · Firm income: $40,500
Matched citations: HR 696
Cancer Patient Protection Act of 2015
2015 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare --Prompt pay discount legislation, HR 696 --H.R. 1416 The Cancer Patient Protection Act of 2015
Client expense: — · Firm income: $40,500
Matched citations: H.R. 1416
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2015 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
--Site-neutral payment policy for oncology services under Medicare --Prompt pay discount legislation, HR 696 --H.R. 1416 The Cancer Patient Protection Act of 2015
Client expense: — · Firm income: $40,500
Matched citations: HR 696
Medicare Patient Access to Cancer Treatment Act of 2013
2014 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
HR 800 S 806 -- Amends Part B (Supplementary Medical Insurance) of Title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers. HR 2869 - To amend Title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer care services furnished in the hospital outpatient department and the physician office setting.
Client expense: — · Firm income: $13,500
Matched citations: HR 2869
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
2014 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
HR 800 S 806 -- Amends Part B (Supplementary Medical Insurance) of Title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers. HR 2869 - To amend Title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer care services furnished in the hospital outpatient department and the physician office setting.
Client expense: — · Firm income: $13,500
Matched citations: HR 800
Source: Senate LDA